Operations

Debra Beauregard, director of medical intelligence and innovation at Rady Children’s Health, discusses why some hospitals are cautious about exploring new technologies and how her team evaluates technology solutions to pilot and scale.

The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.

HHS is looking at how the care plan is supporting the patient, says Sandy Griffiths, senior product manager for Homecare Homebase.

CEO of Lirio, Marten den Haring, explains how the company uses its proprietary Large Behavior Model to understand a person’s health behaviors, motivations and decision-making patterns to drive personalized patient engagement in healthcare.

A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device market through anticompetitive bundling and exclusive-deal practices that harmed rival Applied Medical.

The company was granted a preliminary injunction blocking U.S. sales of an alleged copycat fitness tracker by Chinese company Shenzhen Lexqi Electronic Technology Co.

As medical practices seek to implement agentic AI, Michael Clark, OnPoint Healthcare Partners president, recommends constant oversight to ensure agents' work is repeatable, auditable and traceable by a clinical advisory team.

Lakewood Health System's Jim Roeder says building regional alliances enables rural hospitals to share expertise, strengthen defenses and keep care available when cyber incidents happen.

Chethan Sarabu, director of clinical innovation for the health tech hub at Cornell Tech, previews his HIMSS26 talk on AI's environmental impact and actions stakeholders can take to reduce it.

In Part 1 of Season 2 of MobiHealthNews’ Emerging Technologies series, Mark Zhang, acting assistant under secretary for health, explains how innovation is scaling across the VA.